Results 161 to 170 of about 9,511 (209)

Exosomes-based dual drug-loaded nanocarrier for targeted and multiple proliferative vitreoretinopathy therapy. [PDF]

Regen Biomater
Zhao P, Wang J, Huang H, Chen Z, Wang H, Lin Q.   +5 more
europepmc   +1 more source

Proliferative vitreoretinopathy: an update on the current and emerging treatment options. [PDF]

Graefes Arch Clin Exp Ophthalmol
Ferro Desideri L, Artemiev D, Zandi S, Zinkernagel MS, Anguita R.   +4 more
europepmc   +1 more source

Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor [PDF]

イクノ, ヤスシ, 生野, 恭司
core  

Some of the next articles are maybe not open access.

Related searches:

Proliferative Vitreoretinopathy

International Ophthalmology Clinics, 2014
Proliferative vitreoretinopathy is a sophisticated disease that complicates vitreoretinal pathologies like retinal detachments. Since its first description in the 1960s, we have learned a lot about this pathological entity; however, despite a large number of promising laboratory and clinical pharmacological research projects, we are still unable to ...
Carl, Claes, Anna Paula, Lafetá
openaire   +4 more sources

Anterior Proliferative Vitreoretinopathy

American Journal of Ophthalmology, 1988
During a four-year period, 53 of 92 eyes (58%) undergoing vitreoretinal surgery for a retinal detachment with proliferative vitreoretinopathy demonstrated anterior proliferative vitreoretinopathy. We classified anterior proliferative vitreoretinopathy according to tractional direction, location, extent, and severity.
H, Lewis, T M, Aaberg
openaire   +2 more sources

Mechanisms in proliferative vitreoretinopathy

Ophthalmology Clinics of North America, 2002
The wound-healing paradigm for proliferative vitreoretinopathy has provided numerous avenues for investigation into the pathobiology of the process. The emerging picture is a complex interaction of cytokines, matrix proteins, and metalloproteinases influencing cell behavior and resulting in the formation of undesirable periretinal membranes.
Ivana K, Kim, Jorge G, Arroyo
openaire   +2 more sources

Primary Retinectomy in Proliferative Vitreoretinopathy

American Journal of Ophthalmology, 2010
To describe the functional and anatomic results of retinectomy without scleral buckling for anterior proliferative vitreoretinopathy in eyes that did not undergo previous buckling surgery.Retrospective, nonrandomized, interventional case series.We reviewed the results of 123 consecutive cases of retinectomy for rhegmatogenous retinal detachment ...
Tan HS, Mura M, Lesnik-Oberstein SY, de Smet MD   +3 more
openaire   +3 more sources

PROLIFERATIVE VITREORETINOPATHY

Retina, 1987
Light- and electron-microscopic studies of 43 eyes with retroretinal membranes are presented. Associated features were severe blunt or penetrating injury, total retinal detachment, surbretinal proteinaceous exudate, and concomitant presence of preretinal fibrocellular or fibrovascular proliferations.
S R, Wilkes, A M, Mansour, W R, Green
openaire   +2 more sources

Interventions for Proliferative Vitreoretinopathy

JAMA Ophthalmology
Clinical QuestionWhat is the efficacy of pharmacologic interventions in preventing proliferative vitreoretinopathy?Bottom LineThere is limited high-quality evidence to support currently available pharmacological options for prevention of proliferative vitreoretinopathy.
Wilson X, Wang, Maggie, Xing, Rajendra S, Apte   +2 more
openaire   +2 more sources